Unichem Pharmaceuticals
3 federal recalls on file. We monitor every CPSC, FDA, USDA, and NHTSA notice for Unichem Pharmaceuticals and translate it into plain English — free weekly digest, optional same-day alerts.
- 2026-02-18FDA-DrugClass IIIStop using Unichem Doxazosin 4 mg tablets
Unichem Pharmaceuticals distributed 60,000 tablets of Doxazosin 4 mg with incorrect imprinting on the tablets themselves. This labeling error could cause confusion about the medication's identity and strength. The affected lot is GDSH25006, which expires in August 2027.
- 2026-02-11FDA-DrugClass IIStop using Unichem bisoprolol/hydrochlorothiazide tablets
Unichem Pharmaceuticals is recalling one lot of bisoprolol fumarate and hydrochlorothiazide tablets (2.5 mg/6.25 mg) because they contain higher-than-allowed levels of N-Nitroso Bisoprolol, a potentially harmful impurity. The affected lot was manufactured in India and distributed nationwide.
- 2025-09-24FDA-DrugClass ICyclobenzaprine Hydrochloride Tablets, USP, 10 mg, 90-count bottle, RX only, Manufactured by: Unichem Laboratories, Ltd, Pilerne Ind. Estate, Pilerne, Bardez, Goa, India; Manufactured for: Unichem Pharmaceuticals (USA), Inc. East Brunswick, NJ. NDC 29300-415-19.
Labeling: Label Mix Up; Bottles of Meloxicam USP, 7.5mg, 90-count tablets (yellow in color), were labeled as Cyclobenzaprine Hydrochloride Tablets USP, 10 mg 90-count tablets (blue in color).
Get notified about new Unichem Pharmaceuticals recalls
Free weekly digest. We email when a new federal recall affects Unichem Pharmaceuticals or anything else in your household.
Get the Sunday Brief